Integrated Biopharma Inc Q1 FY2021 Earnings Call

Integrated Biopharma Inc (INBP)

Earnings Call FY2021 Q1 Call date: 2020-11-12 Concluded

Quarter scorecard

Revenue

$12.75M

+11.8% YoY

Diluted EPS

$0.02

+100% YoY

Gross margin

11.2%

-1.1 pp YoY

Net income

$516,000

+65.4% YoY

Contract Manufacturing $12.34M

Other Nutraceutical Business $416,000